SCHEMBL2813667

SCHEMBL2813667

NC(=O)c1nc(CCC(=O)Nc2ccc3[nH]nnc3c2)[nH]c1NC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 3/20 0.40
USP2 O75604 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
RECQL P46063 1/20 0.40
PARP1 P09874 1/20 0.39
TNKS O95271 4/20 0.38
TNKS2 Q9H2K2 1/20 0.38
MMP2 P08253 2/20 0.37
MMP9 P14780 2/20 0.37
MMP8 P22894 2/20 0.37
MMP13 P45452 2/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2814846 0.94 PARP1 (0.46) ALDH1A1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL13133024 0.90 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL2814887 0.88 MAPT (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL2813663 0.86 MCHR1 (0.45) ALDH1A1
SCHEMBL13133021 0.84 PARP1 (0.42) ALDH1A1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL2816645 0.84 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL13133022 0.83 PARP1 (0.41) ALDH1A1MAPTUSP2TDP1PARP1
SCHEMBL13133028 0.81 MCHR1 (0.42) ALDH1A1PARP1
SCHEMBL17957279 0.79 MCHR1 (0.45) ALDH1A1MAPT
SCHEMBL2815670 0.77 NTRK1 (0.40) ALDH1A1MAPTPARP1MMP2MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249132-A1 IMIDAZOLE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249132-A1 IMIDAZOLE DERIVATIVES SDHA, SDHB, TPD52L2 ALDH1A1 198/4885CYP1A2 287/4885CYP3A4 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.